Heartburn drug suspended from sale - US retailer CVS has become the latest to suspend the sale of a heartburn drug being investigated for links to cancer. The move comes after concern in several countries over the presence of impurities in Zantac and other ranitidine products. Canada and France have already announced Zantac recalls. The US and the European Union are investigating. Health authorities say there is no immediate risk, but patients have been advised to consult a doctor who can prescribe alternatives to ranitidine.
Health Pass- The French Constitutional Council will announce on the 5th of August the exact details of the government’s health pass regulations follow...
Read More
In Corsica, the Prefect of the Haute-Corse department has announced that establishments open to the public such as bars and restaurants will have to c...
Read More
U-Turns- Many people say they're confused about the fresh restrictions aimed at reducing the spread of coronavirus in the Alpes Maritimes....
Read More
Aude inferno- A massive fire that’s so far destroyed more than 900 hectares of forest land in the Aude department is still not completely under contro...
Read More
